Trial Transparency Needed to Boost Trust

Russia has announced a Covid-19 vaccine, raising questions over the drug's safety and efficacy. Few details of the research have yet been released to the public, fuelling concerns that Russia's vaccine may not have fulfilled the required safety standards. So to help us answer the question of is this really the vaccine we're waiting for, we reached out to Dr. Jean-Louis Excler, Program Director at the International Vaccine Institute, an independent international organisation based in Seoul.

Image credit: AFP PHOTO / RUSSIAN DIRECT INVESTMENT FUND